e-therapeutics’ operational update for H119 (six months to July 2018) highlighted progress in strengthening the NDD (network-driven drug discovery) platform; business development activities; and drug discovery programmes.
04 Oct 2018
Progress in all areas, and a longer cash runway
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Progress in all areas, and a longer cash runway
e-Therapeutics plc (ETX:LON) | 10.6 0 0.0% | Mkt Cap: 62.2m
- Published:
04 Oct 2018 -
Author:
Mick Cooper PhD -
Pages:
3
e-therapeutics’ operational update for H119 (six months to July 2018) highlighted progress in strengthening the NDD (network-driven drug discovery) platform; business development activities; and drug discovery programmes.